4//SEC Filing
Perone Thomas Michael 4
Accession 0001209191-20-000452
CIK 0001636651other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 7:47 PM ET
Size
5.5 KB
Accession
0001209191-20-000452
Insider Transaction Report
Form 4
Perone Thomas Michael
SVP, General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-01-01+75,000→ 75,000 totalExercise: $4.15Exp: 2030-12-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001771761
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 7:47 PM ET
- Size
- 5.5 KB